Emergent initiates $50m expansion, expects to hire 60

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/Neznam)
(Image: Getty/Neznam)
Emergent BioSolutions has initiated a $50m multi-year expansion at the company’s Baltimore, MD-based fill/finish facility.

The expansion – expected to be completed in 2021 – will see the addition of a new isolator enclosed fill line.

Groninger & Co. will install the FlexPro 50 filler with isolator technology and an integrated Christ lyophilizer at the company's facility in Baltimore​. The line will have the capability to fill vials, syringes, and cartridges.

Additionally, Emergent BioSolutions will be adding a second autoclave to increase its sterilization capacity and provide manufacturing redundancy.

The addition also will provide new cold storage space to support 2-8⁰c and -20⁰c requirements, new stability chambers, new media fill incubators, and additional warehousing and office space, according to the company.

An additional 60 new jobs are expected to be created in the next three years, according to the contract development and manufacturing organization​ (CDMO).

BJ Hull, vice president, general manager and site head at the Camden facility, said in a press release: “This $50 million investment further demonstrates our commitment to meeting and exceeding the expectations of our customers as well as to stimulating economic growth and creating jobs in Baltimore.”

Related news

Show more

Related products

show more

Why Blister Packaging: Things to Consider

Why Blister Packaging: Things to Consider

Catalent Pharma Solutions | 03-Dec-2020 | Insight Guide

The decision to use blister packaging for either clinical trials or commercial drug manufacturing comes with a host of factors to consider. Pharmaceutical...

Innovations in OSD

Innovations in OSD

Recorded the 06-Oct-2020 | Webinar

This DFE series of educational webinars looks at innovations in Oral Solid Dose Forms with the emergence of advanced technologies such as Continuous Manufacturing...

Strategies to Achieve Successful Approval & Launch

Strategies to Achieve Successful Approval & Launch

Catalent Pharma Solutions | 03-Sep-2020 | Data Sheet

There are several key considerations to how companies should approach commercial-scale manufacturing that may aid the success of their biologic’s launch...

Related suppliers

Follow us

Products

View more

Webinars